EMA/EMI for Psychiatrically Hospitalized Emerging Adults Who Drink to Cope
Project CHOICE: Developing a Personalized-Feedback EMA/EMI Intervention for Emerging Adults Leaving Psychiatric Partial Hospitalization
2 other identifiers
interventional
60
1 country
1
Brief Summary
The goal of this proposed study is to evaluate an ecological momentary assessment plus an ecological momentary intervention (EMA+EMI) for emerging adults in a psychiatric partial hospitalization program who drink to cope with negative affect (NA) as compared to personalized feedback only. This intervention combines a personalized feedback intervention (PFI) with EMA technology and tailored EMI text messaging (PFICope+EMI). PFICope+EMI not only aims to reduce drinking to cope, but also alcohol use and NA. This study consists of a 6-week randomized controlled treatment trial to test the PFIcope+EMI intervention as compared to personalized normative feedback only (PNF).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 17, 2021
CompletedFirst Posted
Study publicly available on registry
October 12, 2021
CompletedStudy Start
First participant enrolled
February 6, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2025
CompletedApril 6, 2025
April 1, 2025
2.6 years
September 17, 2021
April 3, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Drinks per Drinking Days
Drinks per drinking day assessed using the Timeline Followback (TLFB)
6-week follow-up
Secondary Outcomes (3)
Drinking Motives
6-week follow-up
Alcohol-related problems
6-week follow-up
Alcohol Outcome Expectancies
6-week follow-up
Other Outcomes (8)
Drinks per Drinking Days
12-week follow-up
Drinks per Drinking Days
6-month follow-up
Drinking Motives
12-week follow-up
- +5 more other outcomes
Study Arms (2)
PNF
ACTIVE COMPARATORParticipants in the PNF condition will receive normative feedback only on their alcohol use.
PFIcope+EMI
EXPERIMENTALThe 6-week PFIcope+EMI includes: 1) an in-person personalized feedback session to present feedback on problems with drinking to cope, discuss the individual's use of alcohol to cope, and generate coping skills messages to be used in the EMI intervention; 2) EMA to monitor affect, intention to drink, coping skills usage, alcohol use, drinking to cope post-discharge; 3) tailored text messages (EMI) based on EMA (individualized coping skills messages when NA and intention to drink are reported).
Interventions
An EMA plus EMI intervention to decrease drinking to cope behaviors among emerging adults receiving psychiatric treatment.
Eligibility Criteria
You may qualify if:
- between 18 and 25 years of age
- reported alcohol use at least 3x weekly over past month and at least one day per week, on average, of binge drinking (as defined as 4+ drinks/2 hours for men and 3+ drinks/2 hours for women)
- self-reported use of coping motive (mean of 2+ on coping subscale of MDMQ-R, indicating they drink to cope at least "some of the time")
- current anxiety and/or depression symptomatology (as assessed CES-D scores above cut-off for high risk for clinical depression and GAD-7 scores above cut-off for moderate to severe anxiety)
- owns a smartphone capable of downloading EMA app.
You may not qualify if:
- current DSM-5 diagnosis of moderate/severe substance use disorder (other than alcohol, cannabis, or nicotine) as assessed by research staff via SCID
- a history of psychotic disorder or current psychotic symptoms as assessed by research staff via SCID
- current suicidal/homicidal ideation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Butler Hospital
Providence, Rhode Island, 02906, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ana M Abrantes, Ph.D.
Butler Hospital/Alpert Medical School of Brown University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 17, 2021
First Posted
October 12, 2021
Study Start
February 6, 2023
Primary Completion
September 30, 2025
Study Completion
October 1, 2025
Last Updated
April 6, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share